Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years

Published:2016-10-07 Issue:1 Volume:120 Page:56-60
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Yaxley John W.¹²,Lah Kevin²³,Yaxley Julian P.⁴,Gardiner Robert A.²⁵,Samaratunga Hema⁶,MacKean James¹

Affiliation:

1. Wesley Medical Centre; Brisbane Qld Australia

2. Royal Brisbane and Women's Hospital; Brisbane Qld Australia

3. University of Queensland School of Medicine; Brisbane Qld Australia

4. Townsville Hospital; Brisbane Qld Australia

5. UQ Centre for Clinical Research; Brisbane Qld Australia

6. Aquesta Pathology; Brisbane Qld Australia

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13659/fullpdf

Reference19 articles.

1. Ambiguities within the ASTRO consensus definition of biochemical failure: never assume all is equal;Williams;Int J Radiat Oncol Biol Phys,2004

2. Long term results of the M.D. Anderson randomised dose - escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008

3. Comparison of convention - dose vs high-dose conformal radiation therapy in clinically localised adenocarcinoma of the prostate: a randomised control;Zietman;JAMA,2005

4. Escalated - dose verses standard - dose conformal radiotherapy in prostate cancer: first results of the MRC RT 01 randomised control trial;Dearnaly;Lancet Oncol,2007

5. Prostate preservation by combined external beam and HDR brachytherapy and nodal negative prostate cancer patients. ….(abstract);Kovacs;Int J Radiat Oncol Biol Phys,1996

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Positive Biopsy Core Rate on Low-dose-rate Brachytherapy Outcomes in Intermediate-risk Prostate Cancer;Anticancer Research;2023-09-29

2. Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group;Radiotherapy and Oncology;2023-03

3. References;An Insider's Perspective of Prostate Cancer;2023

4. HDR prostate brachytherapy plan robustness and its effect on in‐vivo source tracking error thresholds: A multi‐institutional study;Medical Physics;2022-04-19

5. Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa);Cancer/Radiothérapie;2021-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3